San Diego, CA, United States of America

Maina Ndungu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Zafrens, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maina Ndungu: Innovator in Drug Discovery

Introduction

Maina Ndungu is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of drug discovery through her innovative work. With a focus on enhancing assay techniques, her inventions are paving the way for advancements in medical research.

Latest Patents

Maina Ndungu holds a patent for "Perturbation beads for use in assays." This invention discloses uniquely labeled perturbation beads that can be used alone or in combination with a capture bead. These beads are particularly useful in drug discovery, especially in assays conducted in a mapped assay device. The uniquely labeled perturbation bead allows for correlating the sequence of nucleic acids and other components from a lysed cell to the specific examination area where the nucleic acid was retrieved. She has 1 patent to her name.

Career Highlights

Maina is currently employed at Zafrens, Inc., where she continues to develop innovative solutions in the field of drug discovery. Her work is characterized by a commitment to improving the accuracy and efficiency of assays, which are critical in the development of new drugs.

Collaborations

Some of her notable coworkers include Kandaswamy Vijayan and Ravi Ramenani. Their collaborative efforts contribute to the innovative environment at Zafrens, Inc., fostering advancements in research and development.

Conclusion

Maina Ndungu is a trailblazer in the field of drug discovery, with her patented innovations significantly impacting assay techniques. Her work exemplifies the importance of innovation in advancing medical research and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…